glp-1-directed nmda receptor antagonism for obesity treatment

glp-1-directed nmda receptor antagonism for obesity treatment Emerging Role of GLP-1 Receptor Agonists for the Treatment of MASH glp-1-directed nmda receptor antagonism for

Name: glp-1-directed nmda receptor antagonism for obesity treatment Emerging Role of GLP-1 Receptor Agonists for the Treatment of MASH glp-1-directed nmda receptor antagonism for
Brand: adenglobal.org
SKU: 2437989729
Price: 29.10 USD
Availability: InStock
Rating: 4.684 (10 reviews)

SKU: 2437989729

4.7

USD29.10 USD77.10

Pay in 4 interest-free payments of $7.28 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 13 - Aug 18

Description

Upon activation of the GLP-1 receptor, cAMP levels increase, which activates the cAMP response element-binding protein (CREB) ( Furthermore, GLP-1R activation increases cAMP and alters downstream signaling pathways, including PKA, PI3K, PKC, and AKT, all of which contribute to its neuroprotective effects (Zhou et al., 2019)